48 related articles for article (PubMed ID: 12165272)
1. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.
Stohl W; Cheema GS; Briggs WS; Xu D; Sosnovtseva S; Roschke V; Ferrara DE; Labat K; Sattler FR; Pierangeli SS; Hilbert DM
Clin Immunol; 2002 Aug; 104(2):115-22. PubMed ID: 12165272
[TBL] [Abstract][Full Text] [Related]
2. Blood B Lymphocyte Stimulator (BLyS)/BAFF levels may reflect natural immunity to HIV in highly exposed uninfected Beninese Commercial Sex Workers.
Sabourin-Poirier C; Fourcade L; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Sci Rep; 2016 Aug; 6():32318. PubMed ID: 27561453
[TBL] [Abstract][Full Text] [Related]
3. α1Proteinase inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 disease.
Bristow CL; Babayeva MA; LaBrunda M; Mullen MP; Winston R
PLoS One; 2012; 7(2):e31383. PubMed ID: 22363634
[TBL] [Abstract][Full Text] [Related]
4. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
Cancro MP; D'Cruz DP; Khamashta MA
J Clin Invest; 2009 May; 119(5):1066-73. PubMed ID: 19411764
[TBL] [Abstract][Full Text] [Related]
5. Serum IgE levels in Korean patients with human immunodeficiency virus infection.
Park JH; Shin BC; Do BH; Oh JT; Lee JM; Kim SW; Kim NS
Korean J Intern Med; 2002 Jun; 17(2):88-93. PubMed ID: 12164096
[TBL] [Abstract][Full Text] [Related]
6. Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells.
Albanese M; Chen HR; Gapp M; Muenchhoff M; Yang HH; Peterhoff D; Hoffmann K; Xiao Q; Ruhle A; Ambiel I; Schneider S; Mejías-Pérez E; Stern M; Wratil PR; Hofmann K; Amann L; Jocham L; Fuchs T; Ulivi AF; Besson-Girard S; Weidlich S; Schneider J; Spinner CD; Sutter K; Dittmer U; Humpe A; Baumeister P; Wieser A; Rothenfusser S; Bogner J; Roider J; Knolle P; Hengel H; Wagner R; Laketa V; Fackler OT; Keppler OT
Cell Rep Med; 2024 Apr; 5(4):101483. PubMed ID: 38579727
[TBL] [Abstract][Full Text] [Related]
7. Impacts of plasma microbial lipopolysaccharide translocation on B cell perturbations and anti-CD4 autoantibody production in people with HIV on suppressive antiretroviral therapy.
Fu X; Cheng D; Luo Z; Heath SL; Adekunle R; McKinnon JE; Martin L; Sheng Z; Espinosa E; Jiang W
Cell Biosci; 2023 May; 13(1):78. PubMed ID: 37138358
[TBL] [Abstract][Full Text] [Related]
8. Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease.
Yu X; Li Z; Zhou Z; Kilby JM; Jiang W
Epidemiology (Sunnyvale); 2013 Feb; 3():120. PubMed ID: 24795844
[TBL] [Abstract][Full Text] [Related]
9. IgG from individuals without atopy arising as mediators of a nonatopic profile in human peripheral CD4+ T cells.
Cunha FRM; Fagundes BO; Machado NR; França CN; Victor JR
Ann Allergy Asthma Immunol; 2024 Jun; 132(6):770-772. PubMed ID: 38521342
[No Abstract] [Full Text] [Related]
10. 2023 APHL/ISNS Newborn Screening Symposium.
Olney RS; Bonham JR; Schielen PCJI; Slavin D; Ojodu J
Int J Neonatal Screen; 2023 Oct; 9(4):. PubMed ID: 37873845
[TBL] [Abstract][Full Text] [Related]
11. Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.
Doyon-Laliberté K; Aranguren M; Poudrier J; Roger M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328792
[TBL] [Abstract][Full Text] [Related]
12. High TNFSF13B expression as a predictor of poor prognosis in adrenocortical carcinoma.
Mao Y; Alimu P; Wang C; Ma W; Zhuo R; Sun F
Transl Androl Urol; 2021 Aug; 10(8):3275-3285. PubMed ID: 34532252
[TBL] [Abstract][Full Text] [Related]
13. B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection.
Borhis G; Trovato M; Chaoul N; Ibrahim HM; Richard Y
Front Immunol; 2017; 8():1338. PubMed ID: 29163465
[TBL] [Abstract][Full Text] [Related]
14. The Role of BAFF System Molecules in Host Response to Pathogens.
Sakai J; Akkoyunlu M
Clin Microbiol Rev; 2017 Oct; 30(4):991-1014. PubMed ID: 28855265
[TBL] [Abstract][Full Text] [Related]
15. Subversion of the B-cell compartment during parasitic, bacterial, and viral infections.
Borhis G; Richard Y
BMC Immunol; 2015 Mar; 16():15. PubMed ID: 25884828
[TBL] [Abstract][Full Text] [Related]
16. IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.
Chagnon-Choquet J; Fontaine J; Poudrier J; Roger M; ;
PLoS One; 2014; 9(7):e101949. PubMed ID: 25003989
[TBL] [Abstract][Full Text] [Related]
17. The impact of inflammation and immune activation on B cell differentiation during HIV-1 infection.
Ruffin N; Thang PH; Rethi B; Nilsson A; Chiodi F
Front Immunol; 2011; 2():90. PubMed ID: 22566879
[TBL] [Abstract][Full Text] [Related]
18. Influence of dendritic cells on B-cell responses during HIV infection.
Poudrier J; Chagnon-Choquet J; Roger M
Clin Dev Immunol; 2012; 2012():592187. PubMed ID: 22461837
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell status modulates the outcome of HIV-related B cell disease progression.
Poudrier J; Roger M
PLoS Pathog; 2011 Aug; 7(8):e1002154. PubMed ID: 21901089
[No Abstract] [Full Text] [Related]
20. Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.
Haas A; Zimmermann K; Oxenius A
J Virol; 2011 Dec; 85(23):12102-13. PubMed ID: 21849433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
